HK1007431A1 - Acid stable dideoxynucleosides active against the cytopathic effects of human immunodefiency virus - Google Patents

Acid stable dideoxynucleosides active against the cytopathic effects of human immunodefiency virus

Info

Publication number
HK1007431A1
HK1007431A1 HK98105811A HK98105811A HK1007431A1 HK 1007431 A1 HK1007431 A1 HK 1007431A1 HK 98105811 A HK98105811 A HK 98105811A HK 98105811 A HK98105811 A HK 98105811A HK 1007431 A1 HK1007431 A1 HK 1007431A1
Authority
HK
Hong Kong
Prior art keywords
dideoxynucleosides
active against
acid stable
cytopathic effects
chem
Prior art date
Application number
HK98105811A
Other languages
English (en)
Inventor
Victor E Marquez
John S Driscoll
Christopher Kuo-Hou Tseng
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of HK1007431A1 publication Critical patent/HK1007431A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98105811A 1987-04-17 1998-06-20 Acid stable dideoxynucleosides active against the cytopathic effects of human immunodefiency virus HK1007431A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3940287A 1987-04-17 1987-04-17

Publications (1)

Publication Number Publication Date
HK1007431A1 true HK1007431A1 (en) 1999-04-09

Family

ID=21905250

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105811A HK1007431A1 (en) 1987-04-17 1998-06-20 Acid stable dideoxynucleosides active against the cytopathic effects of human immunodefiency virus

Country Status (9)

Country Link
EP (1) EP0287313B1 (xx)
JP (2) JPH0613547B2 (xx)
AT (1) ATE116656T1 (xx)
AU (1) AU603219B2 (xx)
CA (1) CA1340645C (xx)
DE (1) DE3852665T2 (xx)
HK (1) HK1007431A1 (xx)
IL (1) IL86040A (xx)
WO (1) WO1988007861A1 (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
DE68924319T2 (de) * 1988-03-16 1996-05-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
GB8920534D0 (en) * 1989-09-11 1989-10-25 Wellcome Found Antiviral compounds
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US6399754B1 (en) 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US5670633A (en) * 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US6005087A (en) * 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5677437A (en) * 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
US5623070A (en) * 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
US5965722A (en) * 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US7119184B2 (en) 1991-08-12 2006-10-10 Isis Pharmaceuticals, Inc. Oligonucleotides having A-DNA form and B-DNA form conformational geometry
US6307040B1 (en) 1992-03-05 2001-10-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
WO2004044136A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928773A (en) * 1958-11-17 1960-03-15 It Prodotti Schering Soc Process for preparing inosine
JPS5686200A (en) * 1979-12-17 1981-07-13 Yamasa Shoyu Co Ltd Adenine nucleoside and its preparation
US4357824A (en) * 1980-09-15 1982-11-09 General Electric Company Method for determining volatilization rates of dissolved volatiles from solid waste materials
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4489052A (en) * 1982-09-15 1984-12-18 Sloan-Kettering For Cancer Research Quantitative autoradiographic mapping of focal herpes simplex virus encephalitis using a radiolabeled antiviral drug
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
AU575918B2 (en) * 1984-03-06 1988-08-11 Sloan-Kettering Institute For Cancer Research Hepatitis treatment with pyrimidine nucleoside compounds
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives

Also Published As

Publication number Publication date
EP0287313B1 (en) 1995-01-04
IL86040A (en) 1993-03-15
ATE116656T1 (de) 1995-01-15
AU1684488A (en) 1988-11-04
JPH069680A (ja) 1994-01-18
EP0287313A3 (en) 1989-06-14
JPH0613547B2 (ja) 1994-02-23
JPH01501628A (ja) 1989-06-08
DE3852665T2 (de) 1995-05-11
EP0287313A2 (en) 1988-10-19
WO1988007861A1 (en) 1988-10-20
AU603219B2 (en) 1990-11-08
CA1340645C (en) 1999-07-13
IL86040A0 (en) 1988-09-30
DE3852665D1 (de) 1995-02-16

Similar Documents

Publication Publication Date Title
HK1007431A1 (en) Acid stable dideoxynucleosides active against the cytopathic effects of human immunodefiency virus
ES2094150T3 (es) Derivado de triazina y herbicida que lo contiene a titulo de ingrediente activo.
ES8206488A1 (es) Un procedimiento para preparar compuestos de purina y piri- midina
ES2006142A6 (es) Un metodo para preparar derivados de acidos quinolincarboxilicos
TW340115B (en) Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis
ES8502703A1 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ATE36331T1 (de) Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung.
MY101880A (en) Benzoylphenylureas, the preparation thereof and the use thereof in pest control.
JPS5772970A (en) Azolylalkyl derivatives, manufacture and use as fungicide
ATE131510T1 (de) Wasserverschmutzungverhindernde zusammensetzungen
EP0567207A3 (en) Method for reducing the impurities in the aqueous solutions of the monomers.
DK287282A (da) Fremgangsmaade til fremstilling af adamantylethylaminer
ATE83377T1 (de) Antianaerobe naphthyridinverbindungen.
GB9020924D0 (en) Compound,use and preparation
MX9206930A (es) Nuevos compuestos
IL73042A (en) Oximes of beta-(1-azolylmethyl)-beta-hydroxyaryl-acetaldehydes and aralkylketones,their preparation and their use as fungicides
JPS55111447A (en) Novel 3-amino-4-homoisotwistane derivative
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
ES8707254A1 (es) Un procedimiento para preparar un derivado de imidazopiridazina
DE69222438D1 (de) Aids-virus-infektion hemmende zusammensetzung
EA199700188A1 (ru) Пестициды
ES8503646A1 (es) Procedimiento para la obtencion de derivados de bencilurea.
IE792347L (en) Benzimidazole derivatives.
JPS559027A (en) Stable germicide composition
ES8703886A1 (es) Procedimiento para la obtencion de n-(diamino-fosfinil)halo-benzamidas

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080411